Cme vs Nasdaq: revenue, profit, margins and growth compared
Cme brought in $6.5B of revenue in fiscal 2025, Nasdaq $8.3B in fiscal 2025. Revenue changed by +6.4% at Cme and +11.6% at Nasdaq on the year before, so Nasdaq grew faster. Cme kept 62.5% of its revenue as net profit, Nasdaq 21.6%. Free cash flow was $4.2B at Cme and $2B at Nasdaq.
Fiscal years as each company reports them; the two may end in different months.
Questions about Cme and Nasdaq
Which is bigger by revenue, Cme or Nasdaq?
Nasdaq is bigger by revenue: $8.3B in fiscal 2025, against $6.5B for Cme in fiscal 2025.
Which keeps more of its revenue as profit, Cme or Nasdaq?
Cme had a net margin of 62.5% in fiscal 2025; Nasdaq had 21.6% in fiscal 2025.
Which grew revenue faster, Cme or Nasdaq?
In their latest fiscal years revenue changed by +6.4% at Cme and +11.6% at Nasdaq.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.